SCWorx Announces First Installment of Purchase Order For 48 Million COVID-19 Rapid Testing Units Over Twenty-Four Weeks at $35 Million Dollars Per Week

Stock Information for SCWorx Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About SCWorx Corp.

SCWorx Signs Letter of Intent to Acquire an Environmental Services Company
SCWorx Shareholders Overwhelmingly Approve Reverse Stock Split at Annual Meeting
New York Hospital Selects SCWorx for Data Management and Workday Implementation Assistance
SCWorx Announces New Hospital Customer
SCWorx Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement
SCWorx Announces New Product and the Signing of Two New Hospital Customers
SCWorx Announces the Renewal and Significant Expansion of an Existing Contract with a New England Hospital
SCWorx Extends Agreement with one of the Top Five Integrated Delivery Networks in the U.S.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.